Aveanna Healthcare Holdings Inc (AVAH) — closed signal from June 2, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on August 31, 2026 — +92.4% at the close.
Predicted vs. what happened
AVAH price · publication thesis → realized outcomesplit-adjusted
$6.60 – $7.10Entry zone — fair-value band
$6.98Published — price the day we called it
$8.44Target — the price the thesis aimed for
$14.00Peak — highest point inside the window, not a realized return
$13.42Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 22 days.
At window close
+92.4%
realized, from the publication price to the last close inside the windowPeak gain
+100.7%
peak, from the publication price — not a realized returnS&P 500, same window
+1.2%
SPY over the identical days, dividend-adjustedWindow close
$13.42
last close inside the window, ended August 31, 2026Peak price
$14.00
peak on August 27, 2026 — not a realized returnDays to target
22
The thesis — published June 2, 2026
Predicted growth
+21%
over the measurement windowTarget price
$8.44
the price the thesis aimed forEntry zone
$6.60 – $7.10
the fair-value band we waited forPrice at publication
$6.98
published June 2, 2026Confidence
74%
how strongly the data lined upTimeframe
Short-term (0–3 months)
Aveanna looks interesting after buying Family First Homecare and raising its full-year forecast. Recent results beat expectations and the stock has been sold off, creating a recovery setup. Debt and the challenge of combining businesses are meaningful, so confidence is moderate even though demand for home care is steady.
Primary drivers
- Acquisition expands where the company can serve patients
- Higher forecast supports the idea of business recovery
- Home-based care tends to hold up in weaker economies
- Debt load and merging operations make conviction cautious
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.